You are here

Global

Bivalent COVID-19 booster outperforms monovalent version --new study

A new Italian study finds that estimated relative vaccine effectiveness (rVE) was 49.3% for the bivalent (two-strain) booster and 26.9% for the monovalent (single-strain) booster, with protection lasting at least 4 months for the bivalent booster and waning fast for the monovalent version. The study appears in The Lancet Infectious Diseases.

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Global
howdy folks
Page loaded in 1.222 seconds.